153 related articles for article (PubMed ID: 37994781)
1. Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry.
Pečinka L; Vlachová M; Moráň L; Gregorová J; Porokh V; Kovačovicová P; Almáši M; Pour L; Štork M; Havel J; Ševčíková S; Vaňhara P
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2646-2653. PubMed ID: 37994781
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
3. Using quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify low level monoclonal proteins.
Campbell L; Simpson D; Ramasamy K; Sadler R
Clin Biochem; 2021 Sep; 95():81-83. PubMed ID: 34058191
[TBL] [Abstract][Full Text] [Related]
4. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
5. Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma.
Deulofeu M; Kolářová L; Salvadó V; María Peña-Méndez E; Almáši M; Štork M; Pour L; Boadas-Vaello P; Ševčíková S; Havel J; Vaňhara P
Sci Rep; 2019 May; 9(1):7975. PubMed ID: 31138828
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
Mehra N; Gopisetty G; Subramani J; Dhanasekar S; Rajamanickam A; Perumal Kalaiyarasi J; Karunakaran P; Kannan K; Rajaraman S; Rajkumar T
Ann Clin Biochem; 2023 Sep; 60(5):339-348. PubMed ID: 37158306
[TBL] [Abstract][Full Text] [Related]
7. MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins.
Moore LM; Cho S; Thoren KL
Clin Chim Acta; 2019 May; 492():91-94. PubMed ID: 30790545
[TBL] [Abstract][Full Text] [Related]
8. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine.
Barnidge DR; Krick TP; Griffin TJ; Murray DL
Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2057-60. PubMed ID: 26443406
[TBL] [Abstract][Full Text] [Related]
9. Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study.
Peng W; den Boer MA; Tamara S; Mokiem NJ; van der Lans SPA; Bondt A; Schulte D; Haas PJ; Minnema MC; Rooijakkers SHM; van Zuilen AD; Heck AJR; Snijder J
J Proteome Res; 2023 Sep; 22(9):3022-3028. PubMed ID: 37499263
[TBL] [Abstract][Full Text] [Related]
10. MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins.
Fatica EM; Martinez M; Ladwig PM; Murray JD; Kohlhagen MC; Kyle RA; Kourelis T; Lust JA; Snyder MR; Dispenzieri A; Murray DL; Willrich MAV
Clin Biochem; 2021 Nov; 97():67-73. PubMed ID: 34384797
[TBL] [Abstract][Full Text] [Related]
11. MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance.
Barceló F; Gomila R; de Paul I; Gili X; Segura J; Pérez-Montaña A; Jimenez-Marco T; Sampol A; Portugal J
PLoS One; 2018; 13(8):e0201793. PubMed ID: 30071092
[TBL] [Abstract][Full Text] [Related]
12. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
International Myeloma Working Group
Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
[TBL] [Abstract][Full Text] [Related]
13. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
[TBL] [Abstract][Full Text] [Related]
14. Screening for and diagnosis of monoclonal gammopathy.
Chong YP; Lim SM; Loh TP; Mollee P; Wijeratne N; Choy KW
J Clin Pathol; 2023 Nov; 76(11):727-733. PubMed ID: 37604683
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
16. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools.
Bhattacharyya S; Epstein J; Suva LJ
Dis Markers; 2006; 22(4):245-55. PubMed ID: 17124346
[TBL] [Abstract][Full Text] [Related]
18. The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?
Giles HV; Wechalekar A; Pratt G
Br J Haematol; 2022 Aug; 198(4):641-653. PubMed ID: 35514140
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen and Sulfur Co-doped Carbon-Dot-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Imaging for Profiling Bisphenol S Distribution in Mouse Tissues.
Lin Z; Wu J; Dong Y; Xie P; Zhang Y; Cai Z
Anal Chem; 2018 Sep; 90(18):10872-10880. PubMed ID: 30139256
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy and spurious hypophosphatemia.
Weisbord SD; Chaudhuri A; Blauth K; DeRubertis FR
Am J Med Sci; 2003 Feb; 325(2):98-100. PubMed ID: 12589234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
